Purchase Order 75N91021P00495
Award Date 5/28/21
Potential Completion Date 6/27/21
Potential Value $12K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Newark, CA 94560, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price $33,717 federal contract was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation. The contract is for the provision of ACD's proprietary RNAscope technology, which enables the visualization and quantification of RNA biomarkers. This technology will be used to analyze human pluripotent stem cell-derived...
- Advanced Cell Diagnostics, Inc. (ACD) has been awarded a $26,945 firm fixed price purchase order by the National Institutes of Health's National Institute of Neurological Disorders and Stroke (NIH NINDS) to provide RNAScope HiPlex Probes and Reagents. The solicitation sought these specific products from ACD to support research at NIH NINDS aimed at identifying and quantifying 40 RNA molecules in mouse brain tissue using ACD's proprietary RNAScope assay method. Delivery within one week of order...
- This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation. The $18,690.00 contract provides ACD's proprietary RNAscope assay biological products, including kits, reagents, and probes, to support various biomedical research efforts across NIH. These products enable the visualization and...
- This contract award is to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation, by the National Institute of Child Health and Human Development (NICHD), a component of the National Institutes of Health (NIH). The $5,110.00 firm-fixed-price purchase order is for ACD's proprietary RNAscope technology and related products to support biomedical research efforts across various NIH institutes and other federal agencies. ACD's expertise in RNA detection has made it a valuable...
- The National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), awarded a $26,857 firm-fixed-price purchase order contract to Advanced Cell Diagnostics, Inc. (ACD) for the procurement of RNAscope In-House Assay or equivalent technology. This contract was awarded on July 21, 2025, with a completion date of September 25, 2025. ACD is a for-profit molecular diagnostics company specializing in advanced RNA detection technologies, including the RNAscope platform....
- This firm-fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian federal agency, to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation. The $10,488.08 contract is for the provision of ACD's proprietary RNAscope technology and related products, which enable the visualization and quantification of RNA biomarkers. This contract supports biomedical research efforts across various National Institutes of...
- Advanced Cell Diagnostics, Inc. has been awarded an $11,183.20 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide RNAscope assay biological products including kits, reagents and probes. As a leader in molecular pathology, Advanced Cell Diagnostics will supply its proprietary RNAScope platform and accompanying products to support the federal research programs of the Department of Health and Human Services agency....
- This is a firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation. The contract, valued at $78,439.00, is for the provision of PERIOPERATIVE MEDICINE PROBES. ACD is a for-profit manufacturer of molecular diagnostics products, specializing in RNA detection technologies such as RNAscope. The company has a strong track record of supporting federal biomedical...
- This is a $13,793.20 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Cell Diagnostics, Inc. (ACD), a molecular diagnostics company specializing in RNA detection technologies. The contract is for the delivery of 12 custom RNAscope probes and an RNAscope fluorescent reagent kit, which will support various biomedical research efforts across NIAID and...
- This firm-fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) Clinical Center to Advanced Cell Diagnostics, Inc. (ACD), a molecular diagnostics company specializing in RNA detection technologies. The $20,000.00 contract supports ACD's provision of its proprietary RNAscope reagents, kits, probes, and related services to aid various biomedical research efforts across NIH and its institutes, including the National Cancer Institute, National Institute of...
RNASCOPE TECHNOLOGY IS REQUIRED FOR US TO RELIABLY IDENTIFY THE SOURCE OF THE TGFBETA ISOFORMS THAT ARE SIGNALING IN NORMAL TISSUES AND TUMORS. NO OTHER TECHNOLOGY ENABLES US TO DO THIS ON SAMPLES WITH MINIMAL MATERIAL (EG HEART VALVES). THE INFORMAT
Posted 5/28/21
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 5/28/21 |